Braeburn Pharmaceuticals files for IPO

Dec 30 (Reuters) - Braeburn Pharmaceuticals Inc filed with

U.S. regulators on Friday to raise up to $150 million in an

initial public offering, seven months after its implant to treat

opioid addiction was approved in the United States.

Read more